Jan Šimák

8.3k total citations
55 papers, 1.8k citations indexed

About

Jan Šimák is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jan Šimák has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Hematology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jan Šimák's work include Prion Diseases and Protein Misfolding (12 papers), Platelet Disorders and Treatments (11 papers) and Extracellular vesicles in disease (7 papers). Jan Šimák is often cited by papers focused on Prion Diseases and Protein Misfolding (12 papers), Platelet Disorders and Treatments (11 papers) and Extracellular vesicles in disease (7 papers). Jan Šimák collaborates with scholars based in United States, Czechia and Bangladesh. Jan Šimák's co-authors include Monique P. Gelderman, Karel Holada, Jaroslav G. Vostal, Silvia H. De Paoli Lacerda, Jana Šemberová, Silvia H. De Paoli, Jan Janota, Jennifer B. Hall, Anil K. Patri and Scott E. McNeil and has published in prestigious journals such as Journal of Biological Chemistry, Nano Letters and Blood.

In The Last Decade

Jan Šimák

53 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Šimák United States 23 911 337 263 250 243 55 1.8k
Weiqi Lu China 26 886 1.0× 176 0.5× 161 0.6× 194 0.8× 205 0.8× 120 2.5k
Alexander G. Khandoga Germany 20 649 0.7× 239 0.7× 160 0.6× 692 2.8× 259 1.1× 25 2.2k
Ciprian Tomuleasa Romania 26 1.3k 1.5× 340 1.0× 330 1.3× 336 1.3× 141 0.6× 181 2.6k
Abraham Schneider United States 28 1.1k 1.2× 258 0.8× 400 1.5× 275 1.1× 57 0.2× 73 3.3k
Changhao Cui China 23 587 0.6× 101 0.3× 319 1.2× 381 1.5× 142 0.6× 50 1.6k
Karel Holada Czechia 20 678 0.7× 192 0.6× 173 0.7× 123 0.5× 197 0.8× 65 1.3k
Gourab Bhattacharjee United States 25 957 1.1× 320 0.9× 130 0.5× 233 0.9× 266 1.1× 45 2.1k
Hirokazu Miki Japan 21 508 0.6× 299 0.9× 501 1.9× 91 0.4× 241 1.0× 81 1.6k
Ling Lu China 22 823 0.9× 471 1.4× 178 0.7× 198 0.8× 68 0.3× 64 1.8k
David M. Weinreich United States 20 685 0.8× 115 0.3× 427 1.6× 576 2.3× 360 1.5× 32 2.8k

Countries citing papers authored by Jan Šimák

Since Specialization
Citations

This map shows the geographic impact of Jan Šimák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Šimák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Šimák more than expected).

Fields of papers citing papers by Jan Šimák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Šimák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Šimák. The network helps show where Jan Šimák may publish in the future.

Co-authorship network of co-authors of Jan Šimák

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Šimák. A scholar is included among the top collaborators of Jan Šimák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Šimák. Jan Šimák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoshi, M. Reza, Mehulkumar Patel, Elena Karnaukhova, et al.. (2024). Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cells. Cellular and Molecular Life Sciences. 81(1). 376–376.
3.
Filipová, Marcela, et al.. (2018). An effective “three-in-one” screening assay for testing drug and nanoparticle toxicity in human endothelial cells. PLoS ONE. 13(10). e0206557–e0206557. 13 indexed citations
4.
Kotarek, Joseph A., Silvia H. De Paoli, Jan Šimák, et al.. (2016). Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events. Journal of Pharmaceutical Sciences. 105(3). 1023–1027. 92 indexed citations
6.
Carpenter, John, Barry Cherney, Stacey Ma, et al.. (2010). Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation. Biologicals. 38(5). 602–611. 49 indexed citations
7.
Panigaj, Martin, et al.. (2010). Underestimation of the expression of cellular prion protein on human red blood cells. Transfusion. 51(5). 1012–1021. 20 indexed citations
8.
Gelderman, Monique P. & Jan Šimák. (2008). Flow Cytometric Analysis of Cell Membrane Microparticles. Methods in molecular biology. 484. 79–93. 73 indexed citations
9.
Gelderman, Monique P., et al.. (2007). Reduced erythroid cell and erythropoietin production in response to acute anemia in prion protein-deficient (Prnp−/−) mice. Blood Cells Molecules and Diseases. 40(3). 302–307. 9 indexed citations
10.
Holada, Karel, Jan Šimák, Paul Brown, & Jaroslav G. Vostal. (2007). Divergent expression of cellular prion protein on blood cells of human and nonhuman primates. Transfusion. 47(12). 2223–2232. 12 indexed citations
11.
Šimák, Jan & Monique P. Gelderman. (2005). Cell Membrane Microparticles in Blood and Blood Products: Potentially Pathogenic Agents and Diagnostic Markers. Transfusion Medicine Reviews. 20(1). 1–26. 250 indexed citations
12.
Šimák, Jan, et al.. (2004). Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 125(6). 804–813. 107 indexed citations
13.
Šimák, Jan, Karel Holada, & Jaroslav G. Vostal. (2002). Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biology. 3(1). 11–11. 76 indexed citations
14.
15.
Janota, Jan, et al.. (2001). Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. European Journal of Clinical Investigation. 31(11). 978–983. 49 indexed citations
16.
Vostal, Jaroslav G., Karel Holada, & Jan Šimák. (2001). Expression of cellular prion protein on blood cells: Potential functions in cell physiology and pathophysiology of transmissible spongiform encephalopathy diseases1. Transfusion Medicine Reviews. 15(4). 268–281. 15 indexed citations
17.
Šimák, Jan, et al.. (2000). Development of multiple organ failure in critically ill newborns under AT III substitution.. PubMed. 101(2). 143–8. 1 indexed citations
18.
Šimák, Jan, Karel Holada, Jan Janota, & Zbyněk Straňák. (1999). Surface Expression of Major Membrane Glycoproteins on Resting and TRAP-Activated Neonatal Platelets. Pediatric Research. 46(4). 445–445. 27 indexed citations
19.
Straňák, Zbyněk, et al.. (1996). Changes in alveolar-arterial oxygen difference and oxygenation index during low-dose nitric oxide inhalation in 15 newborns with severe respiratory insufficiency. European Journal of Pediatrics. 155(10). 907–910. 3 indexed citations
20.
Holada, Karel, Jan E. Dyr, Jiřı́ Suttnar, & Jan Šimák. (1991). Comparison of rat and human major platelet glycoproteins. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 99(2). 399–403. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026